Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type
Authors not listed
Myrexis Inc. · 2006
Abstract
Open-label treatment with MPC-7869 for participants in a previous randomized study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2006). Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type. <em>Myrexis Inc.</em>. https://clinicaltrials.gov/study/NCT00380276
Vancouver
Anonymous. Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type. Myrexis Inc.. 2006.
BibTeX
@misc{anon2006OpenLa,
title = {Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type},
author = {Anonymous},
journal = {Myrexis Inc.},
year = {2006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JHSPH Center for Clinical Trials 2009
Open access · US-GOV
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Composite Interceptive Med Science 2018
Open access · US-GOV
Clinical Evaluation of Turmeric and Tulsi Polyherbal Formulation in the Management of Frailty in Elderly Population: An Open Label Randomized Controlled Trial
Kırıkkale University 2023
Open access · US-GOV
Comparison of Kinesiophobia, Balance, Falling and Walking Speeds of the Cognitively Frail Elderly With Alzheimer's Dementia With the Physically Fragile Elderly.
Neurological Associates of West Los Angeles 2023
Open access · US-GOV
Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty
Quark Pharmaceuticals 2009
Open access · US-GOV
Phase II Open Label Multicenter, Prospective, Randomized, Age Related Macular Degeneration, Comparator Controlled Study Evaluating PF-04523655 Versus Ranibizumab In The Treatment Of Subjects With Choroidal Neovascularization (MONET Study).
AGE 2013
Open access · OA